INTERNATIONAL PATENT: BREAKPOINT THERAPEUTICS GMBH FILES APPLICATION FOR "PHENYLPYRROLIDINE DERIVATIVES AND THEIR USE AS POI-THETA DERIVATIVES"

GENEVA, July 1 -- BREAKPOINT THERAPEUTICS GMBH (Essener Bogen 72241922419 Hamburg) filed a patent application (PCT/EP2024/087644) for "PHENYLPYRROLIDINE DERIVATIVES AND THEIR USE AS POI-THETA DERIVATIVES" on Dec 19, 2024. With publication no. WO/2025/132946, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AMOUZEGH, Patricia (c/o Evotec (UK) LtdDorothy Crowfoot Hodgkin Campus114 Innovation DriveMilton ParkAbingdon Oxfordshire OX14 4RZ), BARDELL-COX, Oliver (c/o Evotec (UK) LtdDorothy Crowfoot Hodgkin Campus114 Innovation D...